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Objectives: The objective of this study was to examine cognitive and clinical differences among three groups of
patients diagnosed with psychogenic nonepileptic seizures (PNESs): those with posttraumatic stress disorder
(PTSD), those with a history of trauma but no PTSD, and those without a history of trauma.
Methods: Seventeen patients who were conﬁrmed to have PTSD based on the Trauma Symptom Inventory-2
(TSI-2) and clinical interview were compared with 29 patients without PTSD who had experienced trauma
and 17 patients who denied experiencing trauma.We analyzed demographic data, psychiatric information, trau-
ma characteristics, and neuropsychological variables in these groups.
Results: Our study revealed that patients with PNESs with comorbid PTSD performed signiﬁcantly worse on ep-
isodic verbal memory (narrative memory); had greater self-reported Total, Verbal, and Visual Memory impair-
ments; and had higher substance abuse history and use of psychopharmacological agents compared with
patients without PTSD regardless of a history of trauma.
Conclusion: The present study showed that patients with PNESs diagnosed with PTSD exhibited memory func-
tions that were signiﬁcantly different from those in patients with PNESs who do not carry a diagnosis of PTSD
(regardless of history of trauma). Furthermore, these speciﬁc cognitive ﬁndings in narrative memory are consis-
tent with those reported in patients with PTSD alone. The present ﬁndings contribute to further identifying dis-
crete intragroup differences within PNESs. Identifying a speciﬁc psychopathological subgroup such as PTSD will
allow clinicians to accurately select treatment.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Psychogenic nonepileptic seizures (PNESs) are events that resemble
epileptic seizures but lack electrophysiological correlates or clinical
evidence for epilepsy, and, instead, there is evidence for a psychogenic
nature. Up to 90% of patients with PNESs have been reported to have
histories of signiﬁcant traumatic experiences, with particularly high in-
stances of childhood sexual and physical abuse, compared with control
groups and the general population [1,2]. Previous studies have obtained
percentages of patientswith PNES and PTSD features ranging from22 to
100% [3,4]. In a recent study, our program reported that 45 (73.8%) out
of 61 patients experienced at least one traumatic event in their lifetime,
and 12 (26.66%) of those 45 fulﬁlled the criteria for posttraumatic stresssy Group, 820 Second Avenue,
0; fax: +1 212 661 7496.
).
. This is an open access article underdisorder (PTSD) based on the Trauma Symptom Inventory-2 (TSI-2) [5].
This high variability in percentages of patients with PNESs with comor-
bid PTSD could be due to the inconsistency in measures used to diag-
nose PTSD across these studies or differences between samples with
PNESs.
The long-term effects that trauma and subsequent PTSD may have
on cognitive development have been the focus of trauma research for
decades [6,7]. Investigations of PTSD not associated with PNESs have
found discrete psychological and neuropsychological ﬁndings that
differentiate this group of patients from healthy controls as well as
from individuals with a history of trauma who have not developed
PTSD. Themost robust cognitive deﬁcits appear to involve memory sys-
tems, with patients experiencing greater impairments in verbal declar-
ative memory function along with relatively intact visual memory
[8–27]. In recent years, the importance of including performance valid-
ity testing into neuropsychological batteries to avoid erroneous conclu-
sions regarding cognitive impairments has been recommended [28].
Indeed, with regard to PTSD, a study this year [29] found that failurethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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with poorer performance on almost all cognitive tests and concluded
that the assessment of respondent validity is necessarywhen evaluating
this population.
Patients with PNESs have also been reported to perform below nor-
mal limits on neuropsychological testing compared with standardized
norms [1,30] on a range of cognitive functions with no particular deﬁcit
pattern. Some authors [31] have revealed that a substantial number of
patients with PNESs are not putting forth sufﬁcient effort on cognitive
testing, which might explain many of these reported cognitive weak-
nesses. Other researchers [32] suggest that these numbers are being
overestimated depending on the design of the study. In view of this
debate, performance validity testing is a necessary part of standard neu-
ropsychological batteries with patients with PNESs and PTSD. The goal
of our present study was to determine whether patients dually diag-
nosed with PNESs and PTSD have a cognitive pattern which is similar
to the patterns reported in the literature for PTSD. If this were true,
these particular patients may beneﬁt more from empirically validated
PTSD treatment as a ﬁrst line of action rather than other less speciﬁc
treatments.
2. Material and methods
This study included 79 consecutive patients with a diagnosis of
PNESs conﬁrmed with inpatient video-EEG monitoring who went on
to complete a comprehensive neuropsychological battery between
2008 and 2013 and who had an IQ N 70.
All of the subjects were interviewed by a neuropsychologist who
assessed for a history of trauma. Trauma was classiﬁed as physical
abuse (i.e., bruising, broken bones, whipmarks, stabwounds, concussions
resulting from blows to the head), rape/sexual abuse (i.e., touching/
fondling and/or forced oral sex or vaginal/anal intercourse), loss or
death of signiﬁcant other (i.e., death of a child, unwanted estrangement,
and prolonged shunning from family), severemedical history (multiple
and painful surgical interventions or treatments), witnessing the abuse
of another (i.e., seeing a sibling or mother being raped or beaten), and
severe emotional abuse (repeated verbal insults, marginalization and
neglect by caretakers, or continuous verbal bullying). A tally of types
of trauma was recorded. Since some patients had experienced multiple
traumatic events, age of the ﬁrst traumatic episode was classiﬁed as
“age of initial trauma.” A diagnosis of PTSD was made based on the
information obtained from the clinical interview (according to
DSM-IV criteria) combined with the scores from the TSI-II. Charts
were reviewed to determinewhether there was a history of traumat-
ic head injury with or without loss of consciousness. Current medica-
tions being taken at the time of the assessment were recorded;
patients reported whether these were being prescribed to treat
depression, anxiety, psychotic symptoms, and/or sleep disorders.
Age at PNES onset and duration as well as other demographic vari-
ables were also logged.
Patients were categorized into one of three groups: Group 1 report-
ed psychological trauma and were diagnosed with PTSD, Group 2 re-
ported a history of psychological trauma but failed to fulﬁll criteria for
PTSD, and Group 3 denied a history of trauma.
2.1. Exclusion criteria
The initial number of 79 patients was reduced to 63 because of the
following exclusions: 2 were found to have a dual diagnosis of epilepsy
and PNESs, and 14 were classiﬁed by the neuropsychologist as putting
forth insufﬁcient effort (malingering) based on published cutoffs on
the Test of Memory Malingering (TOMM) [33], a test of performance
validity, behavioral observations suggestive of deﬁcient effort, and/or
veriﬁcation of an active pursuit of a personal injury suit or a disability
petition.2.2. Measures
The standard battery of tests administered to our patients with
PNESs at the Northeast Regional Epilepsy Group includes six cognitive
tests. These measure intelligence, verbal and visual memory, executive
functions, and confrontation naming skills. The TOMM is included in
the battery and serves the purpose of examining the validity of results
obtained. A self-report measure that assesses memory complaints
(verbal, visual, and total) is also completed by all patients.
Six cognitive measures and the Memory Complaints Inventory from
the PNES neuropsychological battery were used for analysis. The Trau-
ma Symptom Inventory-2 (TSI-2) was utilized in determining the diag-
nosis of PTSD along with clinical data. The Test of Memory Malingering
(TOMM) and Wechsler Abbreviated Scale of Intelligence (WASI) were
utilized as part of exclusion criteria demands.
2.2.1. TSI-2
The TSI-2 [34] is a 136-item self-report measure that is used to eval-
uate acute and chronic posttraumatic symptomatology in adults. The
TSI-2 assesses for the effects of sexual and physical assault, intimate
partner violence, combat, torture, motor vehicle accidents, mass casual-
ty events, medical trauma, traumatic losses, and childhood abuse or
neglect. The clinical scales of the instrument measure the extent to
which the respondent endorses twelve trauma-related symptoms in-
cluding the following: Anxious Arousal, Depression, Anger, Intrusive
Experiences, Defensive Avoidance, Dissociation, Somatic Preoccupa-
tions, Sexual Disturbance, Suicidality, Insecure Attachment, Impaired
Self-Reference, and Tension Reduction Behavior. The TSI-2 has been
thoroughly examined with regard to reliability and validity. Predictive
validity of PTSD using the TSI-2 was tested through discriminant
function analysis using the T scores for the Anxious Arousal, Intrusive
Experiences, and Defensive Avoidance scales. An optimally weighted
combination of these TSI-2 scales signiﬁcantly predicted PTSD with a
sensitivity of 1.00 and a speciﬁcity of .88. In our study, we utilized the
diagnostic TSI-2 standard composed of three scales to assess for PTSD:
the Anxious Arousal (anxiety and autonomic hyperarousal), Intrusive
Experiences (i.e., nightmares, ﬂashbacks, upsetting memories), and
Defensive Avoidance (cognitive and behavioral avoidance of distressing
content) scales. These are in line with Criterion B (intrusive recollec-
tions), Criterion C (avoidant/numbing), and Criterion D (hyperarousal)
of the DSM-IV.
The TSI-2 has two symptom validity subscales: Atypical Response
(ATR) and Response Level (RL). According to the testmanual, “adminis-
trations that produce RL T scores of 75 or higher should be considered
invalid”, and “a raw score of 15 T>/= 100 indicates invalidity and is
the recommended cutoff.”
2.2.2. TOMM
The TOMM [33] is a 50-item visual recognition test that is sensitive
to motivation and effort and is speciﬁcally designed to differentiate
between authentic memory impairments and malingering. The TOMM
numerical scores combined with situational variables assist the neuro-
psychologist in making a clinical decision about the effort that is being
put forth on testing. Patients who were excluded from the present
study were determined to be exerting insufﬁcient effort based on the
recommendation stated in the Test of Memory Malingering (TOMM)
professional manual; this includes the following: 1) a combination of
numerical scores (i.e., Trials 1 and 2 of the TOMM), 2) behavioral obser-
vations suggestive of deﬁcient effort, and 3) veriﬁcation of an active
pursuit of a personal injury suit or a disability petition.
2.2.3. WASI
The WASI [35] consists of four subtests: Vocabulary, Similarities,
Block Design, and Matrix Reasoning. For the purpose of this study,
FSIQ was utilized as a criterion for exclusion (FSIQ b 70).
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The Delis–Kaplan Executive Function System (D-KEFS) [36] consists
of 9 stand-alone tests used to evaluate higher level cognitive functions.
The standard battery at our program includes two subtests: Trail
Making and Color–Word Interference. Trail Making 4, a visual–motor
sequencing task that requires alphanumerical shifting, and Color–
Word Interference 3, a test that requires the inhibition of the automatic
response of word-reading in favor of color naming, were included as
cognitive variables.
2.2.5. Wechsler Memory Scale (WMS-III) [37]
The WMS-III consists of 11 subtests, with six primary subtests re-
quired to derive index scores. Logical Memory I and Logical Memory II
assess immediate and delayed auditory verbal memory that is semanti-
cally organized. Raw scores were the cognitive variables in this study.
2.2.6. Continuous Visual Memory Test (CVMT) [38]
The CVMT comprises 112 complex, ambiguous drawings (e.g., poly-
gons) and irregular nonsense ﬁgures that are presented in succession to
the subject in 7 blocks of 16 stimuli. The 30-minute delayed multiple-
choice recognition raw memory score was a cognitive variable in this
study.
2.2.7. California Verbal Learning Test-II (CVLT-II) [39]
This is a list-learning test that assesses repetition learning, serial po-
sition effects, semantic organization, intrusions, and proactive interfer-
ence. Delayed Spontaneous Recall raw score was a cognitive variable
in this study.
2.2.8. Boston Naming Test (BNT) [40]
This is a test of visual confrontational word retrieval that consists of
60 line drawings in graded difﬁculty. The ﬁnal score included in this bat-
tery is the raw score of spontaneous correct plus correct with semantic
(but not phonemic) cues out of a total of 60.
2.2.9. Memory Complaints Inventory (MCI) [41]
TheMCI is a self-report scale using a 5-item (“not at all” to “extreme-
ly”) Likert scale to rate the severity of self-perceivedmemory problems.
The 57 items are converted to 9 scales (General Memory Problems,
Numeric Information Problems, Visuospatial Memory Problems, Verbal
Memory Problems, Pain Interferes with Memory, Memory Interferes
with Work, Impairment of Remote Memory, Amnesia for Complex
Behavior, and Amnesia for Antisocial Behavior) and a Total of All Symp-
toms, with all scales ranging from 0 to 100% endorsement. The convert-
ed scores are compared with those of reference groups (e.g., Mild Head
Injury, Severe Head Injury, “Normals Instructed to Fake Memory Im-
pairment”) to determine overendorsement of memory problems. For
the purposes of this study, only Verbal Memory, Visuospatial Memory,
and the MCI Total were analyzed.Table 1
Cognitive variables of the sample with PNESs.
Tests Group 1 (PTSD) Group 2 (yes trauma, no
N M SD N M
WASI FSIQ 17 89.41 10.90 29 92.22
CVLT DR 15 7.87 4.26 29 9.59
CVMT DR 16 3.38 2.06 29 3.75
D-KEFS T4 15 7.13 2.92 29 8.97
D-KEFS CW3 13 8.46 3.23 29 6.94
BNT 15 50.73 4.03 29 48.45
WMS LM I 16 9.13 2.527 29 9.19
WMS LM II 16 8.69 2.243 29 9.72
WASI FSIQ:Wechsler Abbreviated Scale of Intelligence Full Scale IQ, CVLT-II DR: California Verb
Delayed Recall, D-KEFS T4 and CW3: Delis–Kaplan Executive Function System TrailMaking 4 an
ory Scale-III Logical Memory.
⁎ Signiﬁcant at p b 0.05. With the exception of the WASI and MCI, all scores are raw scores.2.3. Analysis
Analysis of variance (ANOVA) was used to determine the signiﬁ-
cance of differences between the three patient groups for the two de-
mographic variables (age and years of education) and the cognitive
measures. Cognitive measures included the following: Full Scale IQ
(WASI), Verbal Fluency 4, Color–Word Interference 3 (D-KEFS), Logical
Memory I and Logical Memory II (WMS-III), Delayed Recognition
(CVMT), Delayed Spontaneous Recall (CVLT-II), and Total correct re-
sponses (BNT). Tukey's testwas used for post hoc analyses of signiﬁcant
variables. Pearson chi-square tests between the 3 groups, with adjusted
residuals used for post hoc analyses, were used for the analysis of demo-
graphic and medical factors with categorical variables. IRB approval for
an anonymous archival record review was obtained with removal of
non-relevant PHI (Copernicus IRB NRE1-11-155).
3. Results
Group 1 (patients diagnosed with PTSD) was composed of 17
women with mean age of 45.53 ± 10.74 and years of education of
14.06 ± 2.54. Group 2 (patients with trauma/no diagnosis of PTSD)
was composed of 22 women and 7 men with mean age of 37.65 ±
11.86 and years of education of 13.88± 2.33. Group 3 (patientswhode-
nied a history of trauma)was composed of 17womenwithmean age of
35.29 ± 12.1 and years of education of 14.35 ± 2.47. There was no sig-
niﬁcant difference between these variables or among duration of PNESs
among the groups.
None of the patients in our sample earned scores on the TSI-2 valid-
ity scales that would require their elimination from the study. After
comparing all neuropsychological variables among the three groups,
Logical Memory II (delayed narrative memory) was signiﬁcantly dif-
ferent between the 3 groups (F = 3.65, p = .032). Group 1 earned
lower scores on LM II compared with the other two groups and earned
signiﬁcantly (p = .024) lower scores (8.69 ± 2.24) on this measure
comparedwith Group 3 (10.82± 1.94). Analyses between the 3 groups
on the 3 MCI scales that were examined showed signiﬁcant differences
for self-report on Verbal Memory (F = 14.92, p = .000006), Visuospa-
tial Memory (F = 4.16, p = .02), and the MCI Total (F = 11.1, p =
.0001). For all of the MCI measures, Group 1 scored higher (greater ex-
aggeration) than Groups 2 and 3, which did not signiﬁcantly differ from
each other (Table 1).
When psychological and demographic factors were assessed, only
4 showed signiﬁcant differences between groups,withGroup 1present-
ing with the highest rates compared with the other two groups.
The three groups differed by the use of psychiatric medication, X2
(2df, N = 63) = 12.93, p b .002; substance abuse, X2 (2df, N = 63) =
6.03, p = .049; history of rape, X2 (2df, N = 63) = 9.12, p b .003; and
physical abuse X2 (2df, N=63)= 5.73, p b .017, with Group 1 present-
ing higher incidences of all (Table 2). The presence of traumatic headPTSD) Group 3 (no trauma) F p value
SD N M SD
13.694 17 95.65 12.971 1 0.372
3.627 17 8.41 3.337 1.29 0.283
1.951 17 4 1.541 0.461 0.633
2.927 17 7.12 4.136 2.47 0.093
3.549 16 7.75 3.568 0.94 0.397
10.049 17 47.53 8.931 0.58 0.565
2.429 17 10.47 2.375 1.8 0.174
2.439 17 10.82 1.944 3.65 0.032⁎
al Learning Test-II Delayed Spontaneous Recall, CVMTDR: Continuous Visual Memory Test
d Color–Word Interference 3, BNT: Boston Naming Test, MCI:WMS-III LM:WechslerMem-
Table 2
Historical variables of the sample with PNESs.
Yes/no 1 (PTSD) 2 (no PTSD) 3 (no trauma) c2 p value
Psy meds 15/2 11/22 9/8 12.93 0.002⁎
Sub 13/4 2/28 0/17 6.026 0.049⁎
Sex Tr 13/4 10/22 9.115 0.003⁎
Phys Tr 13/4 31/19 5.728 0.017⁎
Loss Tr 9/8 12/20 1.081 0.299
Med Tr 5/12 4/28 2.118 0.416
Witness Tr 5/12 5/27 1.299 0.254
Psych Tr 5/12 7/25 0.341 0.559
Psy meds: psychopharmacological medications, Sub: substance abuse history, Sex Tr:
trauma—sexual, Phys Tr: trauma—physical, Loss Tr: trauma—loss, Med Tr: trauma—
medical, Witness Tr: Trauma—witness, Psych Tr: psychological trauma.
⁎ Signiﬁcant at p b 0.05.
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4. Discussion
Results from this study showed that patients with PNESs/PTSD had
signiﬁcantly different (lower) verbal declarative memory function rela-
tive to patientswith PNESs without PTSD on a test of narrativememory.
Our sample's verbal memory results resemble those observed in PTSD
(combat-related and sexual abuse-related), according to the growing
body of literature on neuropsychological function in patients with
PTSD who display similar and relative weaknesses in verbal declarative
memory function comparedwith healthy subjects or with subjects with
a history of traumawho have not gone on to develop PTSD [24,26,27]. It
is interesting that a similarly signiﬁcant difference was not detected
between groups on another verbal memory measure (CVLT-II). These
two measures differ in that the CVLT requires the learning of unrelated
lists of words, albeit some can ﬁt into certain semantic categories, while
the LM subtests require the learning and coherent retelling of meaning-
ful content. Patients with PTSD commonly ﬁnd it challenging to present
a clear narrative in therapy sessions. We might speculate that the Logi-
cal Memory subtests are exposing a particular cognitive weakness in
these patients that a list-learning task does not identify (Table 1).
Memory disturbances are predominant in the presentation of PTSD,
in the form of frequent complaints of everyday memory problems
with emotionally neutral material. Our patients with PNESs/PTSD self-
assessed their memory functions (Total, Verbal, and Visual) to be
extremely impaired,muchmore so than the groupwithout PTSD did re-
gardless of trauma history (Table 3). These self-assessments by patients
with PNESs/PTSD were consistent with statistically lower scores on
standardized testing of verbal memory, although not with visual mem-
ory scores.
The group with PNESs/PTSD in the current study reported more
common histories of substance abuse than the rest of the sample with
PNESs, similar to previous reports of patientswith PTSD [42,43]. In addi-
tion, the greater use of psychopharmacological agents found in our
group with PNESs/PTSD might indicate a higher level of psychologicalTable 3
Trauma Symptom Inventory-2 and Memory Complaints Inventory scores.
Tests Group 1 (PTSD) Group 2 (yes tra
N M SD N M
TSI-2 Anxious Arousal 16 72.50 6.143 29 58.38
TSI-2 Intrusive Experience 16 70.69 9.816 29 56.72
TSI-2 Defensive Avoidance 16 67.44 9.187 29 57.72
MCI Verbal 17 70.29 22.74 29 30.17
MCI Visual 17 45.88 22.52 29 27.27
MCI Total 16 53.94 20.93 28 26.57
TSI-2 = Trauma Symptom Inventory-2 and MCI = Memory Complaints Inventory.
⁎ Signiﬁcant at pb 0.05
⁎⁎ Signiﬁcant at pb 0.01distress and symptoms in this group. The presence of higher instances
of sexual and physical abuse (interpersonal trauma) in our sample
with PNESs/PTSD compared with our patients without PTSD is consis-
tent with trauma disorder development.
There are reports in the literature of patients with PNESs performing
below normal limits on neuropsychological testing compared
with standardized norms and with patients diagnosed with epilepsy
[1,30,44,45], although no speciﬁc deﬁcit pattern has been identiﬁed in
PNESs. However, whenwe examined the sample based on the psychiat-
ric diagnosis of PTSD,we identiﬁed relative cognitiveweaknesseswhich
were different than those seen in other patients with PNESs alone and
weremore similar to the verbalmemory patterns reported in the literature
for PTSD alone. In fact, patientswith PNESs/PTSDdiffered signiﬁcantly from
the other patients with PNESs on objective and subjective memory scores.
In contrast with other reports [41], we did not ﬁnd that duration of PNESs
or other historical data explained this poorer memory function.
Relatively weaker verbal memory found in patients with PNESs/
PTSD compared with the other subjects with PNESs is clinically signiﬁ-
cant in that lower episodic verbal memory can inﬂuence treatment out-
come. In fact, Wild and Gur [46] identiﬁed that PTSD non-responders to
cognitive behavioral treatment (CBT) had signiﬁcantly poorer perfor-
mance onmeasures of verbal memory compared with PTSD responders
and demonstrated narrative encoding deﬁcits. Therefore, verbalmemo-
ry deﬁcits may diminish the effectiveness of traditional cognitive-based
treatment and should be considered when deciding on treatment op-
tions. Moreover, our ﬁnding that verbal memory deﬁcits in patients
with PNESs/PTSD more closely resemble cognitive patterns in patients
with PTSD alone indicates that empirically supported treatment for
PTSD [i.e., exposure therapy, cognitive processing therapy (CPT), and
eye movement desensitization and reprocessing (EMDR)] should be
considered for this subgroup [47].
There are two important elements that were included in this study
with the purpose of strengthening its design. It has been suggested
that cognitive deﬁcits found in many patients with PNESs and PTSD
are in fact due to insufﬁcient effort (malingering) [31] being put forth.
The American Academy of Clinical Neuropsychology [28] recently
published a position paper in which the importance of including testing
of effort in neurocognitive test batteries was indicated. It is for this rea-
son that our study took this into account and controlled for the possibil-
ity of memory malingering by excluding patients using the TOMM and
concordant behavioral observations. Moreover, because a history of a
traumatic brain injury could also have had an effect on the cognitive
measures being used, the presence or absence of this type of injury
was considered and was not found to explain the cognitive differences
seen in our sample.
Because this study utilized several measures, conclusions should be
circumspectly drawn since multiple comparisons increase the potential
for a type-I error. However, these 7 measures are unrelated and do not
have multicollinearity, and, so, they would not signiﬁcantly correlate
with each other. A second limitation is that our sample is missing
those patients who were diagnosed with PNESs through video-EEG
monitoring but did not complete neuropsychological testing becauseuma, no PTSD) Group 3 (no trauma) c2 p value
SD N M SD
8.715 16 56.00 11.069
12.750 16 49.69 10.769
9.602 16 50.13 10.327
23.470 17 36.88 28.68 14.92 0.000**
24.195 16 25.63 23.15 4.16 0.02*
19.778 15 23.13 17.59 11.1 0.0001**
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patients could have different, clinically relevant characteristics, but it
was not possible to examine them. In addition, we did not collect data
on ethnic and racial backgrounds of patients, and important information
regarding cultural variations in PNES pathology and neuropsychological
functions may have been overlooked.
Future studies exploring the neurobiological underpinning of PNESs
within certain types of psychopathologies (i.e., PTSD) can further clarify
the growing body of evidence of differential subgroups within the
overarching classiﬁcation of PNESs. Along similar lines, measurement
of PTSD symptom severity could add to our understanding of these
patients. From a treatment perspective, it will be necessary to examine
treatment response in patients diagnosed with PNESs and PTSD with
diagnostic-speciﬁc treatments (i.e., prolonged exposure—PE or eye
movement desensitization and reprocessing—EMDR) compared with
general psychological treatments (cognitive behavioral treatment).
In sum, identifying a distinctive diagnostic category such as PTSD
supported through cognitive and psychological testing and clinical
interview within the general PNES classiﬁcation is important from a di-
agnostic and treatment perspective. The present ﬁndings provide an
indication that cognitive patterns of patients with PNESs/PTSD more
closely resemble those of patients with PTSD alone compared with
others who have PNESs alone and, therefore, may gain greater beneﬁt
from empirically validated PTSD treatment rather than from other less
speciﬁc treatments.
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